In a podcast recorded a few years ago, I chatted with Allison Haitz, currently Biotechnology Programme Director at Givaudan about R&D, technology transfer and commercialisation. These were originally released in three parts exploring the issues of R&D culture and clock speeds (Part 1), Management, leadership and balance (Part 2) and Equilibrium, academics and policies (Part 3).

We are taking the opportunity to relaunch these as a single podcast, with thanks to Allison and the team at R&D Today, to share some of our thoughts in light of Spiegare's newly minted Service Partner Membership of Cooperative Research Australia.